image

The best stocks to buy since 1993

Latest issue now available

Regenersis

October 2008

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • RGS
  • Price:
  • 77p
Regenersis (RGS) has reported results for the year to 30 June with the group returning to the black to the tune of £5.12m pretax for eps of 15.1p on a low tax charge. The general tenor of the statement was that the restructuring following the merger of its two constituent parts, CRC and Fonebak, is complete. Both businesses were fundamentally sound but had lost their way. The restructuring in FY08 saw the closure of three sites in the UK and Germany whilst a site in Romania was relocated. In addition to this, the year also marked the winding down of its non-core activity, trading mobile phones, a capital intensive and volatile business. Phone trading tends to be a business that consumes a lot of cash and winding down this working ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe